|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 316.40 DKK | -1.48% |
|
+5.82% | -49.31% |
| 12-15 | US FDA grants priority voucher to J&J's blood cancer treatment | RE |
| 12-15 | Eli Lilly Could Get FDA Decision for Weight-Loss Pill Orforglipron by March 2026 | MT |
49
Listed companies
50
Private companies
306
Insiders
Relation chart of related listed companies: Novo Nordisk A/S
Active Relations
Past Relations
Related listed companies: Novo Nordisk A/S
Active Relations
Past Relations
Relationship chart for related private companies: Novo Nordisk A/S
Active Relations
Past Relations
Related private companies: Novo Nordisk A/S
Investment Trusts/Mutual Funds
Financial Conglomerates
Pharmaceuticals: Major
Investment Managers
Pharmaceuticals: Major
Pharmaceuticals: Major
Other Consumer Services
Industrial Specialties
Investment Managers
Miscellaneous Commercial Services
Biotechnology
Biotechnology
Pharmaceuticals: Major
Medical Specialties
Pharmaceuticals: Major
Miscellaneous Commercial Services
Drugstore Chains
Financial Conglomerates
Pharmaceuticals: Major
Miscellaneous Commercial Services
Active Relations
Past Relations
Connection statistics
Active
Inactive
Listed companies
Private companies
Activities of related companies
| Pharmaceuticals: Major | 17 |
| Medical Specialties | 8 |
| Biotechnology | 4 |
| Financial Conglomerates | 3 |
| Miscellaneous Commercial Services | 3 |
| Drugstore Chains | 2 |
| Chemicals: Specialty | 2 |
| Investment Managers | 2 |
| Investment Trusts/Mutual Funds | 1 |
| Information Technology Services | 1 |
Countries of related companies
| Denmark | 56 |
| Sweden | 16 |
| United States | 9 |
| Switzerland | 3 |
| Netherlands | 2 |
| Germany | 2 |
| France | 2 |
| Belgium | 2 |
| Italy | 1 |
| Poland | 1 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition